We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Angiographic and Intravascular Ultrasound (IVUS) Follow-up After Simultaneously Implanted Different Drug-eluting Stents in Same Individuals (AIFSIDDES)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2009 by Liuhuaqiao Hospital.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00973375
First Posted: September 9, 2009
Last Update Posted: September 9, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Liuhuaqiao Hospital
  Purpose
The purpose of this study is to investigate if there is any different follow-up results by angiography and IVUS between two different drug-eluting stents after implanted simultaneously in same individuals.

Condition
Drug Eluting Stent

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional

Further study details as provided by Liuhuaqiao Hospital:

Primary Outcome Measures:
  • Segment and instent restenosis measured by coronary angiography and IVUS. [ Time Frame: at 12 months after implantation ]

Secondary Outcome Measures:
  • Uncovered and malposition of stent. [ Time Frame: at 12 months after implantation. ]

Estimated Enrollment: 30
Study Start Date: May 2009
Groups/Cohorts
Endeavor group and Excel group
Endeavor group: measurements from the vessels implanted Endeavor stent(s). Excel group: measurements from the vessels implanted Excel stent(s).

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
These patients who received two kinds of drug-eluting stent (Endeavor and Excel) im simultaneously.
Criteria

Inclusion Criteria:

  • These patients who received two kinds of drug-eluting stent (Endeavor and Excel) im simultaneously.

Exclusion Criteria:

  • Dual anti-platelet therapy less than 12 months.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00973375


Locations
China, Guangdong
Liuhuaqiao Hospital Recruiting
Guangzhou, Guangdong, China, 510010
Contact: Dingcheng Xiang, MD, Ph.D    +86-20-3665 3325    dcxiang@foxmail.com   
Principal Investigator: Dingcheng Xiang, MD, Ph.D         
Sponsors and Collaborators
Liuhuaqiao Hospital
  More Information

Publications:
Responsible Party: Dingcheng Xiang, MD., Ph.D, Liuhuaqiao Hospital
ClinicalTrials.gov Identifier: NCT00973375     History of Changes
Other Study ID Numbers: LHQ09-003
First Submitted: September 8, 2009
First Posted: September 9, 2009
Last Update Posted: September 9, 2009
Last Verified: September 2009

Keywords provided by Liuhuaqiao Hospital:
Drug-eluting stent
coronary restenosis
coronary thrombosis


To Top